Sveriges Riksbank
22.2.2021 10:31:42 CET | Globenewswire | Press release
| Bid date, 2021-02-22 | |
| Auction date | 2021-02-22 |
| Settlement date | 2021-02-22 |
| Maturity Date | 2021-05-24 |
| Term | 13 weeks |
| Interest rate | The Riksbank´s applicable repo rate |
| Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
| Confirmation of bids to e-mail | eol@riksbank.se |
| Offered volume | Unlimited |
| The lowest accepted bid volume | 50 million SEK |
| Maximum number of bids | 1 |
| Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-02-22
| Bid date, 2021-02-22 | |
| Auction date | 2021-02-22 |
| Settlement date | 2021-02-22 |
| Maturity Date | 2021-08-23 |
| Term | 26 weeks |
| Interest rate | The Riksbank´s applicable repo rate |
| Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
| Confirmation of bids to e-mail | eol@riksbank.se |
| Offered volume | Unlimited |
| The lowest accepted bid volume | 50 million SEK |
| Maximum number of bids | 1 |
| Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-02-22
This is a translation of the Swedish version published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Serstech17.9.2026 18:40:00 CEST | Press release
Serstech receives 10.7 MSEK order from US partner WS Darley and co
Solvay S.A.17.9.2026 17:45:00 CEST | Press release
Participation notifications by Citigroup Inc.
Novo Nordisk A/S17.9.2026 16:14:20 CEST | Press release
Novo: CHMP recommends EU approval of FREHEMGO® (denecimig), the first factor VIIIa mimetic offering monthly, once every two weeks and weekly dosing in a pre-filled pen, for the treatment of haemophilia A
Aptean Inc.17.9.2026 16:00:00 CEST | Press release
Aptean Adds Leading End-to-End Logistics Suite for Road Transport Through Acquisition of European Based FleetGO from Main Capital Partners
Mazama Energy17.9.2026 15:00:00 CEST | Press release
Mazama Energy Raises $135 Million to Scale the World’s Hottest Engineered Geothermal System
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
